Y. Ishikawa

发表

Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy.

J. Bach, Heakyung Kim, J R Bach, 1997, Chest.

Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.

Y. Ishikawa, H. Ogata, Y. Ishikawa, 2009, Journal of cardiology.

Plasma Krebs von den Lungen Glycoprotein, Lung Injury, and Noninvasive Ventilation in Duchenne Muscular Dystrophy

J. Bach, Y. Ishikawa, Y. Ishikawa, 2012, American journal of physical medicine & rehabilitation.

Preservation of central motor conduction in patients with spinal muscular atrophy type II

Y. Ishikawa, H. Matsumoto, T. Imai, 1995, Brain and Development.

A Sensitive Assay of Tumor Necrosis Factor α in Sera from Duchenne Muscular Dystrophy Patients

D. Kobayashi, A. Yagihashi, Kaori Saito, 2000 .

Cardioprotection for Duchenne's muscular dystrophy.

J. Bach, Y. Ishikawa, Y. Ishikawa, 1999, American heart journal.

Duchenne muscular dystrophy: Survival by cardio-respiratory interventions

T. Miura, Y. Ishikawa, H. Ogata, 2011, Neuromuscular Disorders.

Duchenne muscular dystrophy: Survival by cardio-respiratory interventions

T. Miura, Y. Ishikawa, H. Ogata, 2011, Neuromuscular Disorders.

Physical medicine respiratory muscle aids to avert respiratory complications of pediatric chest wall and vertebral deformity and muscle dysfunction.

J. Bach, Y. Ishikawa, 2010, European journal of physical and rehabilitation medicine.

Amyotrophic lateral sclerosis. Successful treatment of mucous plugging by mechanical insufflation-exsufflation.

J. Bach, K. Hanayama, Y. Ishikawa, 1997, American journal of physical medicine & rehabilitation.

Decreased expression of full‐length mRNA for cBCD541 does not correlate with spinal muscular atrophy phenotype severity

Y. Takeshima, H. Nishio, M. Matsuo, 1997, Neurology.

Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy.

J. Bach, Y. Ishikawa, Y. Ishikawa, 2000, American journal of respiratory and critical care medicine.

Nocturnal respiratory failure as an indication of noninvasive ventilation in the patient with neuromuscular disease.

J. Bach, Y. Ishikawa, 1998, Respiration; international review of thoracic diseases.

Molecular Studies of Japanese Patients With Group A Xeroderma Pigmentosum Using Polymerase Chain Reaction and Restriction Fragment Length Polymorphism and Nonradioactive Single Strand Conformation Polymorphism Analyses

Y. Ishikawa, Y. Ishikawa, R. Minami, 1999, Journal of child neurology.

Hybrid survival motor neuron genes in Japanese patients with spinal muscular atrophy

Y. Takeshima, H. Nishio, M. Matsuo, 1999, Acta Neurologica Scandinavica.

High incidence of a survival motor neuron gene/cBCD541 gene ratio of 2 in Japanese parents of spinal muscular atrophy patients: a characteristic background of spinal muscular atrophy in Japan?

Y. Takeshima, H. Nishio, M. Matsuo, 1999, Journal of Neurology.

Correlation between the M and F wave characteristics and the innervated muscle strength in spinal muscular atrophy

Y. Ishikawa, H. Matsumoto, T. Imai, 1998, Brain and Development.

Cardiovascular Considerations in the Management of Neuromuscular Disease

J. Bach, Y. Ishikawa, R. Minami, 1995, Seminars in neurology.

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient

Y. Takeshima, M. Matsuo, M. Yagi, 2001, Brain and Development.

A novel deletion of the dystrophin S-promoter region cosegregating with mental retardation

Y. Takeshima, M. Matsuo, Y. Ishikawa, 1999, Neurology.

Characterization of Neutral and Acidic Glycosphingolipids in Brains of Two Patients with GM1 Gangliosidosis Type 1 and Type 2

Y. Ishikawa, Y. Ishikawa, R. Minami, 1985, Journal of neurochemistry.

Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use v oxygen therapy on pneumonia and hospitalization rates.

J. Bach, R. Kulessa, Y. Ishikawa, 1998, American journal of physical medicine & rehabilitation.

Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.

R Minami, Y. Takeshima, H. Nishio, 1994, The Journal of clinical investigation.

Central nervous system involvement and generalized muscular atrophy in occipital horn syndrome: Ehlers-Danlos type IX A first Japanese case

Y. Ishikawa, R. Minami, S. Wakai, 1993, Journal of the Neurological Sciences.

Biochemical Basis of Type AB GM2 Gangliosidosis in a Japanese Spaniel

P. A. Wood, Yu-Teh Li, Y. Ishikawa, 1987, Journal of neurochemistry.

Amino‐terminal deletion of 53% of dystrophin results in an intermediate Duchenne‐Becker muscular dystrophy phenotype

Y. Takeshima, H. Nishio, M. Matsuo, 1994, Neurology.

Indicators for ventilator use in Duchenne muscular dystrophy.

J. Bach, Y. Ishikawa, Y. Ishikawa, 2011, Respiratory medicine.

Benign Familial Neonatal Convulsions: Clinical Features of the Propositus and Comparison with the Previously Reported Cases

N. Tachi, S. Chiba, Y. Ishikawa, 1991, Acta paediatrica Japonica : Overseas edition.

Duchenne muscular dystrophy

J. Bach, Y. Ishikawa, 1999, Thorax.

Progression in a Case of Kearns-Sayre Syndrome

Y. Ishikawa, Y. Ishikawa, R. Minami, 2000, Journal of child neurology.

Tracheostomy tubes are not needed for Duchenne muscular dystrophy

J. Bach, C. Bianchi, M. Villanova, 2007, European Respiratory Journal.

Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy.

S. Nakatani, Y. Ishikawa, Michiko Kobayashi, 2007, International journal of cardiology.

A management trial for Duchenne cardiomyopathy.

J. Bach, Y. Ishikawa, Y. Ishikawa, 1995, American journal of physical medicine & rehabilitation.

Infantile neuroaxonal dystrophy: axonal changes in biopsied muscle tissue.

N. Tachi, Y. Ishikawa, R. Minami, 1993, Pediatric neurology.

A sensitive assay of tumor necrosis factor alpha in sera from Duchenne muscular dystrophy patients.

D. Kobayashi, A. Yagihashi, Y. Ishikawa, 2000, Clinical chemistry.